Healthcare -
Biotechnology - NASDAQ - CH
$ 3.84
-5.04 %
$ 142 M
Market Cap
-1.94
P/E
MOLN - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities MOLN - Molecular Partners AG
14.4 M
LAST VALUE
234.56%
2 YEAR CAGR
130.86%
5 YEAR CAGR
-17.70%
10 YEAR CAGR